356 related articles for article (PubMed ID: 16424388)
41. NF-κB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ.
Zhi H; Yang L; Kuo YL; Ho YK; Shih HM; Giam CZ
PLoS Pathog; 2011 Apr; 7(4):e1002025. PubMed ID: 21552325
[TBL] [Abstract][Full Text] [Related]
42. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.
Matsumoto J; Ohshima T; Isono O; Shimotohno K
Oncogene; 2005 Feb; 24(6):1001-10. PubMed ID: 15592508
[TBL] [Abstract][Full Text] [Related]
43. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
44. The ESCRT-0 Protein HRS Interacts with the Human T Cell Leukemia Virus Type 2 Antisense Protein APH-2 and Suppresses Viral Replication.
Martini F; Arone C; Hasset A; Hall WW; Sheehy N
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597781
[TBL] [Abstract][Full Text] [Related]
45. Functional and Pathogenic Roles of Retroviral Antisense Transcripts.
Toyoda K; Matsuoka M
Front Immunol; 2022; 13():875211. PubMed ID: 35572593
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of HBZ and Foxp3 mRNA in bronchoalveolar lavage cells taken from human T-lymphotropic virus type 1-associated lung disorder patients.
Nakayama Y; Yamazato Y; Tamayose M; Atsumi E; Yara S; Higa F; Tateyama M; Fujita J
Intern Med; 2013; 52(23):2599-609. PubMed ID: 24292748
[TBL] [Abstract][Full Text] [Related]
47. HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.
Zhao T; Satou Y; Sugata K; Miyazato P; Green PL; Imamura T; Matsuoka M
Blood; 2011 Aug; 118(7):1865-76. PubMed ID: 21705495
[TBL] [Abstract][Full Text] [Related]
48. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB.
Zhao T; Yasunaga J; Satou Y; Nakao M; Takahashi M; Fujii M; Matsuoka M
Blood; 2009 Mar; 113(12):2755-64. PubMed ID: 19064727
[TBL] [Abstract][Full Text] [Related]
49. EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses.
Naito T; Ushirogawa H; Fukushima T; Tanaka Y; Saito M
Virol J; 2019 Dec; 16(1):160. PubMed ID: 31856855
[TBL] [Abstract][Full Text] [Related]
50. [HTLV-I and leukemogenesis].
Yasunaga J; Matsuoka M
Uirusu; 2006 Dec; 56(2):241-9. PubMed ID: 17446673
[TBL] [Abstract][Full Text] [Related]
51. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.
Murata K; Hayashibara T; Sugahara K; Uemura A; Yamaguchi T; Harasawa H; Hasegawa H; Tsuruda K; Okazaki T; Koji T; Miyanishi T; Yamada Y; Kamihira S
J Virol; 2006 Mar; 80(5):2495-505. PubMed ID: 16474156
[TBL] [Abstract][Full Text] [Related]
52. Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases.
Mesnard JM; Barbeau B; Césaire R; Péloponèse JM
Viruses; 2015 Dec; 7(12):6490-505. PubMed ID: 26690203
[TBL] [Abstract][Full Text] [Related]
53. CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1.
Panfil AR; Green PL; Yoder KE
Front Cell Infect Microbiol; 2020; 10():580371. PubMed ID: 33425776
[TBL] [Abstract][Full Text] [Related]
54. Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL.
Raval GU; Bidoia C; Forlani G; Tosi G; Gessain A; Accolla RS
Retrovirology; 2015 Jul; 12():59. PubMed ID: 26140924
[TBL] [Abstract][Full Text] [Related]
55. Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein.
Daian E Silva DSO; Cox LJ; Rocha AS; Lopes-Ribeiro Á; Souza JPC; Franco GM; Prado JLC; Pereira-Santos TA; Martins ML; Coelho-Dos-Reis JGA; Gomes-de-Pinho TM; Da Fonseca FG; Barbosa-Stancioli EF
Virol J; 2023 Dec; 20(1):304. PubMed ID: 38115107
[TBL] [Abstract][Full Text] [Related]
56. The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein.
Accolla RS
Front Immunol; 2022; 13():940131. PubMed ID: 35812456
[TBL] [Abstract][Full Text] [Related]
57. HTLV-1 viral oncoprotein HBZ contributes to the enhancement of HAX-1 stability by impairing the ubiquitination pathway.
Tanaka Y; Mukai R; Ohshima T
J Cell Physiol; 2021 Apr; 236(4):2756-2766. PubMed ID: 32893878
[TBL] [Abstract][Full Text] [Related]
58. HTLV-1 intragenic viral enhancer influences immortalization phenotype
Maksimova V; Smith S; Seth J; Phelps C; Niewiesk S; Satou Y; Green PL; Panfil AR
Front Immunol; 2022; 13():954077. PubMed ID: 35958554
[TBL] [Abstract][Full Text] [Related]
59. Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues.
Shimizu-Kohno K; Satou Y; Arakawa F; Kiyasu J; Kimura Y; Niino D; Sugita Y; Ishikawa F; Matsuoka M; Ohshima K
Cancer Sci; 2011 Jul; 102(7):1432-6. PubMed ID: 21453388
[TBL] [Abstract][Full Text] [Related]
60. Regulation of HTLV-1 transformation.
Ernzen KJ; Panfil AR
Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35169839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
